← Open Payments lookup

TAMMY DUNN: Open Payments

NPI 1407396146 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,132 in 184 payments from 16 companies in 2025. Trend: 2023 $3,186 · 2024 $2,941 · 2025 $4,132

Food & beverage: $4,132
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$1,063
ABBVIE INC.80$1,061
Otsuka America Pharmaceutical, Inc.19$440
Janssen Pharmaceuticals, Inc7$239
Alkermes, Inc.10$222
Axsome Therapeutics, Inc.4$186
Neurocrine BioSciences, Inc.2$152
Teva Pharmaceuticals USA, Inc.10$150
Boston Scientific Corporation1$140
E.R. Squibb & Sons, L.L.C.6$138

Products named: CAPLYTA, VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, Auvelity, INGREZZA, ARISTADA.

Industry payments across PA — which companies pay providers there.